VICP Registry Case Source Bundle
Canonical URL: https://vicp-registry.org/case/USCOURTS-cofc-1_16-vv-01665
Package ID: USCOURTS-cofc-1_16-vv-01665
Petitioner: Gabor Meszaros
Filed: 2017-12-29
Decided: 2018-03-20
Vaccine: Pneumococcal Conjugate Vaccine-13
Vaccination date: 
Condition: shoulder injury related to vaccine administration
Outcome: compensated
Award amount USD: 40000

AI-assisted case summary:
Gabor Meszaros filed a petition for compensation under the National Vaccine Injury Compensation Program on December 20, 2016, alleging a shoulder injury related to vaccine administration (SIRVA) from a Pneumococcal Conjugate Vaccine-13 (PCV-13). He stated the vaccine was administered in the United States, the residual effects lasted over six months, and he had no prior award or settlement. Respondent denied that the PCV-13 caused the alleged right shoulder and arm injury, including swelling, pain, redness, and sensory alterations, or any other injury or current disabilities. The parties filed a joint stipulation on December 29, 2017, agreeing that compensation should be awarded. Chief Special Master Nora Beth Dorsey found the stipulation reasonable and adopted it, awarding Gabor Meszaros a lump sum of $40,000.00, payable to the petitioner, for all items of damages. The decision was issued on March 20, 2018. Petitioner was represented by Edward M. Kraus of the Law Offices of Chicago Kent, and respondent was represented by Claudia Barnes Gangi of the U.S. Department of Justice.

Theory of causation field:
Petitioner Gabor Meszaros filed a petition on December 20, 2016, alleging a shoulder injury related to vaccine administration (SIRVA) from a Pneumococcal Conjugate Vaccine-13 (PCV-13) administered in the United States. The residual effects allegedly lasted over six months. Respondent denied that the PCV-13 caused the alleged right shoulder and arm injury. The parties filed a joint stipulation on December 29, 2017, agreeing to an award. The public decision does not describe the specific onset, symptoms, medical tests, treatments, or expert witnesses. Chief Special Master Nora Beth Dorsey adopted the stipulation, awarding a lump sum of $40,000.00 for all items of damages. The decision was issued on March 20, 2018. The theory of causation is based on the "Table" category of the Vaccine Injury Table, which presumes causation for SIRVA within a specific timeframe following vaccination. Petitioner's counsel was Edward M. Kraus, and respondent's counsel was Claudia Barnes Gangi.

Public staged source text:

================================================================================
DOCUMENT 1: USCOURTS-cofc-1_16-vv-01665-0
Date issued/filed: 2018-03-20
Pages: 7
Docket text: PUBLIC DECISION (Originally filed: 12/29/2017) regarding 27 DECISION Stipulation/Proffer. Signed by Chief Special Master Nora Beth Dorsey. (rp) Service on parties made.
--------------------------------------------------------------------------------
Case 1:16-vv-01665-UNJ Document 36 Filed 03/20/18 Page 1 of 7
In the United States Court of Federal Claims
OFFICE OF SPECIAL MASTERS
No. 16-1665V
Filed: December 29, 2017
UNPUBLISHED
GABOR MESZAROS,
Special Processing Unit (SPU); Joint
Stipulation on Damages;
Petitioner,
Pneumococcal Conjugate Vaccine;
v.
Shoulder Injury Related to Vaccine
Administration (SIRVA)
SECRETARY OF HEALTH AND
HUMAN SERVICES,
Respondent.
Edward M. Kraus, Law Offices of Chicago Kent, Chicago, IL, for petitioner.
Claudia Barnes Gangi, U.S. Department of Justice, Washington, DC, for respondent.
DECISION ON JOINT STIPULATION1
Dorsey, Chief Special Master:
On December 20, 2016, petitioner filed a petition for compensation under the
National Vaccine Injury Compensation Program, 42 U.S.C. §300aa-10, et seq.,2 (the
“Vaccine Act”). Petitioner alleges that he suffered a shoulder injury related to vaccine
administration (“SIRVA”) related to a Pneumococcal Conjugate Vaccine-13 (“PCV-13”).
Petition at 1; Stipulation, filed December 29, 2017, at ¶ 1. Petitioner further alleges that
the vaccine was administered within the United States, that the residual effects of his
injury lasted for more than six months, and that there has been no prior award or
settlement of a civil action for damages on his behalf as a result of his condition.
Petition at 1-4; Stipulation at ¶¶ 3-5. “Respondent denies that the PCV-13 caused
petitioner’s alleged right shoulder and arm injury including swelling, pain, redness and
sensory alterations, any other injury, or his current disabilities.” Stipulation at ¶ 6.
1 Because this unpublished decision contains a reasoned explanation for the action in this case, the
undersigned intends to post it on the United States Court of Federal Claims' website, in accordance with
the E-Government Act of 2002. 44 U.S.C. § 3501 note (2012) (Federal Management and Promotion of
Electronic Government Services). In accordance with Vaccine Rule 18(b), petitioner has 14 days to
identify and move to redact medical or other information, the disclosure of which would constitute an
unwarranted invasion of privacy. If, upon review, the undersigned agrees that the identified material fits
within this definition, the undersigned will redact such material from public access.
2 National Childhood Vaccine Injury Act of 1986, Pub. L. No. 99-660, 100 Stat. 3755. Hereinafter, for
ease of citation, all “§” references to the Vaccine Act will be to the pertinent subparagraph of 42 U.S.C. §
300aa (2012).

Case 1:16-vv-01665-UNJ Document 36 Filed 03/20/18 Page 2 of 7
Nevertheless, on December 29, 2017, the parties filed the attached joint
stipulation, stating that a decision should be entered awarding compensation. The
undersigned finds the stipulation reasonable and adopts it as the decision of the Court
in awarding damages, on the terms set forth therein.
Pursuant to the terms stated in the attached Stipulation, the undersigned
awards the following compensation:
A lump sum of $40,000.00 in the form of a check payable to petitioner.
Stipulation at ¶ 8. This amount represents compensation for all items of
damages that would be available under 42 U.S.C. § 300aa-15(a). Id.
The undersigned approves the requested amount for petitioner’s compensation.
In the absence of a motion for review filed pursuant to RCFC Appendix B, the clerk of
the court is directed to enter judgment in accordance with this decision.3
IT IS SO ORDERED.
s/Nora Beth Dorsey
Nora Beth Dorsey
Chief Special Master
3 Pursuant to Vaccine Rule 11(a), entry of judgment can be expedited by the parties’ joint filing of notice
renouncing the right to seek review.
2

Case 1:16-vv-01665-UNJ Document 36 Filed 03/20/18 Page 3 of 7

Case 1:16-vv-01665-UNJ Document 36 Filed 03/20/18 Page 4 of 7

Case 1:16-vv-01665-UNJ Document 36 Filed 03/20/18 Page 5 of 7

Case 1:16-vv-01665-UNJ Document 36 Filed 03/20/18 Page 6 of 7

Case 1:16-vv-01665-UNJ Document 36 Filed 03/20/18 Page 7 of 7